Syverson Strege & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
6,303
-236
-4% -$55K 0.35% 33
2026
Q1
$1.6M Sell
6,539
-77
-1% -$17.9K 0.38% 30
2025
Q4
$1.37M Buy
6,616
+218
+3% +$43.1K 0.32% 37
2025
Q3
$1.19M Sell
6,398
-127
-2% -$21.8K 0.28% 41
2025
Q2
$997K Buy
6,525
+5,025
+335% +$772K 0.24% 47
2025
Q1
$249K Buy
1,500
+106
+8% +$16.6K 0.08% 68
2024
Q4
$202K Buy
1,394
+65
+5% +$10.1K 0.07% 77
2024
Q3
$215K Sell
1,329
-1,004
-43% -$160K 0.07% 66
2024
Q2
$341K Buy
2,333
+908
+64% +$135K 0.12% 58
2024
Q1
$225K Buy
+1,425
New +$227K 0.08% 67
2023
Q2
Sell
-680
Closed -$105K 349
2023
Q1
$105K Hold
680
0.05% 87
2022
Q4
$120K Sell
680
-56
-8% -$9.67K 0.05% 83
2022
Q3
$120K Hold
736
0.06% 80
2022
Q2
$131K Buy
736
+1
+0.1% +$178 0.05% 82
2022
Q1
$130K Buy
735
+1
+0.1% +$170 0.14% 82
2021
Q4
$126K Sell
734
-45
-6% -$7.37K 0.09% 88
2021
Q3
$126K Buy
779
+103
+15% +$17.6K 0.1% 87
2021
Q2
$111K Hold
676
0.1% 88
2021
Q1
$111K Buy
676
+1
+0.1% +$162 0.12% 84
2020
Q4
$106K Buy
+675
New +$99.6K 0.1% 85

Other funds holding JNJ

Syverson Strege & Co's JNJ Position: Q2 2026 in Review

Syverson Strege & Co reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q2 2026, selling an estimated $55K and leaving 6,303 shares worth $1.6M. The position accounts for 0.35% of the portfolio, ranked #33.

Syverson Strege & Co first reported a position in JNJ in Q4 2020 and has held it in 20 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Syverson Strege & Co held 6,303 shares of Johnson & Johnson worth $1.6M as of Q2 2026.
  • Syverson Strege & Co sold 236 Johnson & Johnson shares in Q2 2026, an estimated $55K.
  • Johnson & Johnson made up 0.35% of Syverson Strege & Co's portfolio in Q2 2026, its #33 holding.
  • Syverson Strege & Co first reported a position in Johnson & Johnson in Q4 2020 and has held it in 20 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Syverson Strege & Co's 13F filing for Q2 2026, filed 6 Aug 2026.